Review Special Issues

Mechanisms and applications of the anti-inflammatory effects of photobiomodulation

  • Received: 05 April 2017 Accepted: 15 May 2017 Published: 19 May 2017
  • Photobiomodulation (PBM) also known as low-level level laser therapy is the use of red and near-infrared light to stimulate healing, relieve pain, and reduce inflammation. The primary chromophores have been identified as cytochrome c oxidase in mitochondria, and calcium ion channels (possibly mediated by light absorption by opsins). Secondary effects of photon absorption include increases in ATP, a brief burst of reactive oxygen species, an increase in nitric oxide, and modulation of calcium levels. Tertiary effects include activation of a wide range of transcription factors leading to improved cell survival, increased proliferation and migration, and new protein synthesis. There is a pronounced biphasic dose response whereby low levels of light have stimulating effects, while high levels of light have inhibitory effects. It has been found that PBM can produce ROS in normal cells, but when used in oxidatively stressed cells or in animal models of disease, ROS levels are lowered. PBM is able to up-regulate anti-oxidant defenses and reduce oxidative stress. It was shown that PBM can activate NF-kB in normal quiescent cells, however in activated inflammatory cells, inflammatory markers were decreased. One of the most reproducible effects of PBM is an overall reduction in inflammation, which is particularly important for disorders of the joints, traumatic injuries, lung disorders, and in the brain. PBM has been shown to reduce markers of M1 phenotype in activated macrophages. Many reports have shown reductions in reactive nitrogen species and prostaglandins in various animal models. PBM can reduce inflammation in the brain, abdominal fat, wounds, lungs, spinal cord.

    Citation: Michael R Hamblin. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation[J]. AIMS Biophysics, 2017, 4(3): 337-361. doi: 10.3934/biophy.2017.3.337

    Related Papers:

    [1] Xinyou Meng, Jie Li . Stability and Hopf bifurcation analysis of a delayed phytoplankton-zooplankton model with Allee effect and linear harvesting. Mathematical Biosciences and Engineering, 2020, 17(3): 1973-2002. doi: 10.3934/mbe.2020105
    [2] Zhichao Jiang, Xiaohua Bi, Tongqian Zhang, B.G. Sampath Aruna Pradeep . Global Hopf bifurcation of a delayed phytoplankton-zooplankton system considering toxin producing effect and delay dependent coefficient. Mathematical Biosciences and Engineering, 2019, 16(5): 3807-3829. doi: 10.3934/mbe.2019188
    [3] Juan Li, Yongzhong Song, Hui Wan, Huaiping Zhu . Dynamical analysis of a toxin-producing phytoplankton-zooplankton model with refuge. Mathematical Biosciences and Engineering, 2017, 14(2): 529-557. doi: 10.3934/mbe.2017032
    [4] Zhenyao Sun, Da Song, Meng Fan . Dynamics of a stoichiometric phytoplankton-zooplankton model with season-driven light intensity. Mathematical Biosciences and Engineering, 2024, 21(8): 6870-6897. doi: 10.3934/mbe.2024301
    [5] Elvira Barbera, Giancarlo Consolo, Giovanna Valenti . A two or three compartments hyperbolic reaction-diffusion model for the aquatic food chain. Mathematical Biosciences and Engineering, 2015, 12(3): 451-472. doi: 10.3934/mbe.2015.12.451
    [6] Xin Zhao, Lijun Wang, Pankaj Kumar Tiwari, He Liu, Yi Wang, Jianbing Li, Min Zhao, Chuanjun Dai, Qing Guo . Investigation of a nutrient-plankton model with stochastic fluctuation and impulsive control. Mathematical Biosciences and Engineering, 2023, 20(8): 15496-15523. doi: 10.3934/mbe.2023692
    [7] Xiaomeng Ma, Zhanbing Bai, Sujing Sun . Stability and bifurcation control for a fractional-order chemostat model with time delays and incommensurate orders. Mathematical Biosciences and Engineering, 2023, 20(1): 437-455. doi: 10.3934/mbe.2023020
    [8] Yuan Ma, Yunxian Dai . Stability and Hopf bifurcation analysis of a fractional-order ring-hub structure neural network with delays under parameters delay feedback control. Mathematical Biosciences and Engineering, 2023, 20(11): 20093-20115. doi: 10.3934/mbe.2023890
    [9] Saswati Biswas, Pankaj Kumar Tiwari, Yun Kang, Samares Pal . Effects of zooplankton selectivity on phytoplankton in an ecosystem affected by free-viruses and environmental toxins. Mathematical Biosciences and Engineering, 2020, 17(2): 1272-1317. doi: 10.3934/mbe.2020065
    [10] Wenjie Yang, Qianqian Zheng, Jianwei Shen, Linan Guan . Bifurcation and pattern dynamics in the nutrient-plankton network. Mathematical Biosciences and Engineering, 2023, 20(12): 21337-21358. doi: 10.3934/mbe.2023944
  • Photobiomodulation (PBM) also known as low-level level laser therapy is the use of red and near-infrared light to stimulate healing, relieve pain, and reduce inflammation. The primary chromophores have been identified as cytochrome c oxidase in mitochondria, and calcium ion channels (possibly mediated by light absorption by opsins). Secondary effects of photon absorption include increases in ATP, a brief burst of reactive oxygen species, an increase in nitric oxide, and modulation of calcium levels. Tertiary effects include activation of a wide range of transcription factors leading to improved cell survival, increased proliferation and migration, and new protein synthesis. There is a pronounced biphasic dose response whereby low levels of light have stimulating effects, while high levels of light have inhibitory effects. It has been found that PBM can produce ROS in normal cells, but when used in oxidatively stressed cells or in animal models of disease, ROS levels are lowered. PBM is able to up-regulate anti-oxidant defenses and reduce oxidative stress. It was shown that PBM can activate NF-kB in normal quiescent cells, however in activated inflammatory cells, inflammatory markers were decreased. One of the most reproducible effects of PBM is an overall reduction in inflammation, which is particularly important for disorders of the joints, traumatic injuries, lung disorders, and in the brain. PBM has been shown to reduce markers of M1 phenotype in activated macrophages. Many reports have shown reductions in reactive nitrogen species and prostaglandins in various animal models. PBM can reduce inflammation in the brain, abdominal fat, wounds, lungs, spinal cord.


    Plankton includes plants and animals that float freely in some fresh water bodies, and almost all aquatic life is based on plankton [1]. Aquatic ecosystems are affected by many factors, including physical and chemical signals in the environment, plankton predation and competition [2,3]. Many scholars have carried out analysis concerning the impact of environment on the ecosystem and the treatment of sewage [4,5,6]. We also know how important plankton itself is to the wealth of marine ecosystems and ultimately to the planet itself. On the one hand, plankton species have positive effects on the environment, such as providing food for marine life, oxygen for animal life; on the other hand, it have harmful effects, such as economic losses to fisheries and tourism due to algae blooms [7,8].

    In recent years, different models of plankton have been established and studied, for example, model with two harmful phytoplankton [9], models with time delays [10,11] and stochastic models [12,13,14]. Toxins produced by harmful phytoplankton tend to be concentrated at higher levels in the food web, as they can spread through the marine food web, affecting herbivores at higher nutrient levels, reaching fish, and through them eventually reaching marine mammals, even in seabirds [9,11]. There is also some evidence that the occurrence of toxin-producing phytoplankton is not necessarily harmful, but rather helps maintain a stable balance of nutrient dynamics through the coexistence of all species. These results suggest that toxin-producing phytoplankton (TPP) play an important role in the growth of zooplankton populations [15].

    It was shown that aquatic plant systems not only have extraordinary memories of climatic events, but also exhibit phenomenological responses based on memory [16,17,18]. The authors noted that environmental factors often alter the expression of chromatin in multiple responsive genes in [19]. Environment-induced chromatin markers are at certain sites and is transmitted by cell division, allowing plants to acquire memories of environmental experiences. This ensures that the plant can adapt to changes in its environment or perform better if the event occurs again. In some cases, it is passed on to the next generation, namely, epigenetic mechanisms. This mechanism is crucial for plants' stress memory and adaptation to the environment, suggesting that plants do form memory and defense mechanisms in certain environments. In addition, a large amount of zooplankton chemical signal learning and corresponding reactions have been documented for aquatic systems [20,21]. In summary, such memory and genetic characteristics can not be neglected for plankton systems.

    As we all know, fractional order derivatives are a good tool for describing the memory and genetic properties of various materials and processes. In other words, the application of fractional order dynamical systems can fully reflect some long-term memory and non-local effects. That is, fractional differential equations have an advantage over classical integer differential equations for describing such systems. In recent years, more and more researchers began to study the qualitative theory and numerical solution of fractional order biological model [22,23,24]. The main reason is that fractional order equations are naturally related to memory systems that exist in most biological systems [25,26]. In addition, fractional-order derivative has also been widely studied and applied in physics[27], engineering [28], biology [29] and many other fields [30,31,32]. At present, there are more than six definitions of fractional derivative, among which Riemann-Liouville and Caputo derivatives are the most commonly used [33]. In the case of fractional Caputo derivative, the initial conditions are expressed by the values of the unknown function and its integer derivative with clear physical meaning [34]. So we will adapt the Caputo's definition in our paper.

    The interactions between phytoplankton and zooplankton do not occur instantaneously in real ecosystems. Instead, the response of zooplankton to contacts with phytoplankton is likely to be delayed due to gestation. For example, in [35], the authors discussed Hopf bifurcation in the presence of time delay required for toxin-phytoplankton maturation. The universality of time-delay coupled system indicates its importance, applicability and practicability in a wide range of biological systems [36,37]. In fact, time delay may change the qualitative behavior of dynamic system [38,39].

    In [40], the authors considered a fractional nutrient-phytoplankton-zooplankton system as follows

    {DαX(t)=x0aXb1XY+c1Y+c2Z,DαY(t)=b2XYd1YZe+Yc3Y,DαZ(t)=d2YZe+YfYZc4Z. (1.1)

    Based on the above model, we classify phytoplankton into non-toxic phytoplankton and toxic phytoplankton and put forward an improved fractional order four-dimensional ecological epidemiological model with delay. The system is established as follows:

    {DαX(t)=ΛμX(t)b1X(t)Y1(t)b2X(t)Y2(t)+c1Y1(t)+c2Y2(t)+c3Z(t),DαY1(t)=k1b1X(t)Y1(t)η1Y1(t)Z(t)h1Y1(t)Y2(t)μ1Y1(t),DαY2(t)=k2b2X(t)Y2(t)η2Y2(t)Z(t)h2Y1(t)Y2(t)μ2Y2(t),DαZ(t)=θ1η1Y1(tτ)Z(tτ)+θ2η2Y2(tτ)Z(tτ)δY2(t)Z(t)μ3Z(t), (1.2)

    subjected to the biologically feasible initial condition:

    X(0)0, Y1(t)=ϕ(t)0, Y2(t)=ψ(t)0, Z(t)=ζ(t)0,t[τ,0], (1.3)

    where ϕ(t), ψ(t) and ζ(t) are continuous function defined on t[τ,0].

    The meaning of state variables and parameters are listed in Table 1; Dα (0<α<1) denotes Caputo fractional differential operator, and the model are based on the following scenarios:

    Table 1.  Description of state variables and parameters in the system (1.2).
    variables Descriptions
    X(t) concentration of nutrient population at time t
    Y1(t) concentration of phytoplankton population at time t
    Y2(t) concentration of toxic phytoplankton population at time t
    Z(t) concentration of zooplankton population at time t
    Parameters Descriptions Default value
    Λ Constant input of nutrient [0.5, 3]
    b1 Nutrient uptake rate for the phytoplankton population [0, 3]
    b2 Nutrient uptake rate for the toxic phytoplankton population [0, 3]
    k1 Nutrient-phytoplankton conversion rate (0, 1)
    k2 Nutrient-toxic phytoplankton conversion rate (0, 1)
    c1 Nutrient recycling rate after the death of phytoplankton (0, 0.1)
    c2 Nutrient recycling rate after the death of toxic phytoplankton (0, 0.1)
    c3 Nutrient recycling rate after the death of zooplankton (0, 0.7)
    η1 Maximal zooplankton ingestion rate (0, 3)
    η2 Maximal zooplankton ingestion rate (0, 2.5)
    θ1 Maximal phytoplankton-zooplankton conversion rate (0, 0.7)
    θ2 Maximal toxic phytoplankton-zooplankton conversion rate (0, 0.8)
    μ Rate of nutrient loss (0, 1.5)
    μ1 Phytoplankton mortality rate (0, 1)
    μ2 Toxic phytoplankton mortality rate (0, 1)
    μ3 Zooplankton death rate (0, 0.6)
    δ Rate of zooplankton decay due to toxin producing phytoplankton (0, 0.2)
    h1 competition effect for phytoplankton (0, 0.3)
    h2 competition effect for toxic phytoplankton (0, 0.3)

     | Show Table
    DownLoad: CSV

    (H1) X(t), Y1(t), Y2(t) and Z(t) represent nutrient population, phytoplankton population, toxic phytoplankton population and zooplankton population, respectively.

    (H2) In real ecosystems, phytoplankton compete with each other for essential resources: nutrients and light. So as the model in the [41], we assume that, for nutrient X(t), phytoplankton population Y1(t) is in competition with toxic phytoplankton population Y2(t), h1 and h2 represent the influence on Y1(t) and Y2(t) in the competition, respectively.

    (H3) Zooplankton do not grow instantaneously after consuming phytoplankton, and pregnancy of predators requires a discrete time delay τ.

    (H4) Zooplankton populations feed only on phytoplankton, and only some of the dead phytoplankton and zooplankton are recycled into nutrients.

    (H5) The toxic phytoplankton has both positive and negative effect on zooplankton, corresponding to the term θ2η2Y2(tτ)Z(tτ) and δY2(t)Z(t) in the last equation of the system(1.2).

    The above assumption (H5) is based on the result in [42]. In fact, the authors concluded that the food selection mechanism of plankton may not yet mature. When different algae of the same species (toxic and non-toxic) coexist, some zooplankton may have poor ability to select between toxic and non-toxic algae, and even show a slight preference for toxic strains.

    The present paper is organized as follows. In section 2, some preliminaries are presented. In section 3, qualitative analysis of the system is performed. In section 4, some numerical examples and simulations are exploited to verify the theoretical results. In the last section, some conclusions and discussions are provided.

    For convenience, we list some of the basic definitions and lemmas of the fractional calculus. In fractional-order calculus, there are many fractional-order integration and fractional-order differentiation that have been defined, for example, the Grunwald-Letnikov (GL) definition, the Riemann-Liouville (RL) definition and the Caputo definition. Since the initial condition is the same as the form of integral differential equation, we will adopt the definition of Caputo in this paper.

    Definition 2.1. [34] The Riemann-Liouville fractional integral of order α>0 for a function f:R+R is defined by

    0Dαtf(t)=1Γ(α)t0(ts)α1f(s)ds, t0.

    Based on this definition of Riemann-Liouville fractional integral, the fractional-order derivative in Riemann-Liouville sense and Caputo sense are given.

    Definition 2.2. [34] The Riemann-Liouville fractional derivative of order α>0 for a function f:R+R is defined by

    RL0Dαtf(t)=dkdtk(0D(kα)tf(t))=1Γ(kα)dkdtkt0(ts)kα1f(s)ds, t0,

    where k1α<k, kN and Γ() is the Gamma function, Γ(α)=+0tα1etdt.

    In particular, when 0<α<1, we have

    RL0Dαtf(t)=1Γ(1α)ddtt0(ts)αf(s)ds.

    Definition 2.3. [34] The Caputo fractional derivative of order α>0 for a function f:R+R is defined by

    C0Dαtf(t)=0D(kα)tf(k)(t)=1Γ(kα)t0(ts)kα1f(k)(s)ds,t0,

    where k1α<k, kN and f(m)(t) is the m-order derivative of f(t). In particular, when 0<α<1, we have

    C0Dαtf(t)=1Γ(1α)t0f(s)(ts)αds.

    Definition 2.4. [34] The two-parameter Mittag-Leffler function is defined by

    Eα,β(z)=+i=0ziΓ(αi+β),α>0,β>0.

    When β=1, the two-parameter Mittag-Leffler function becomes to the one-parameter Mittag- Leffler function, i.e.

    Eα(z)=Eα,1(z)=+i=0ziΓ(αi+1),α>0.

    Theorem 2.5. [43] Consider the following commensurate fractional-order system:

    dαxdtα=f(x),x(0)=x0,

    with 0<α<1 and xRn. The equilibrium points of the above system are calculated by solving the equation: f(x)=0. These points are locally asymptotically stable if all eigenvalues λi of the Jacobian matrix evaluated at the equilibrium points satisfy the inequality: |arg(λi)|>απ2.

    Since the proof of the positivity and boundedness of the solution of the system(1.2) is similar to Theorem 2 and Theorem 3 in the Ref.[38], we will not prove it here.

    The equilibriums of model (1.2) are obtained by solving the following algebraic system

    {ΛμXb1XY1b2XY2+c1Y1+c2Y2+c3Z=0,k1b1XY1η1Y1Zh1Y1Y2μ1Y1=0,k2b2XY2η2Y2Zh2Y1Y2μ2Y2=0,θ1η1Y1Z+θ2η2Y2ZδY2Zμ3Z=0. (3.1)

    By simple calculation, we obtain seven equilibriums of system (1.2), namely:

    (1) E0=(X(0), 0, 0, 0) with X(0)=Λμ.

    (2) E1=(X(1), Y(1)1, 0, 0) with X(1)=μ1k1b1, Y(1)1=μ(1R1)b1(c1R1b1X(0)1), where R1=X(0)X(1). And the feasibility conditions for E1 are simplified as:

    X(0)<X(1)<c1b1orc1b1<X(1)<X(0).

    (3) E2=(X(2), 0, Y(2)2, 0) with X(2)=μ2k2b2, Y(2)2=μ(1R2)b2(c2R2b2X(0)1), where R2=X(0)X(2). And the feasibility conditions for E2 are simplified as:

    X(0)<X(2)<c2b2orc2b2<X(2)<X(0).

    (4) E3=(X(3), Y(3)1, Y(3)2, 0) with Y(3)1=k2b2X(3)μ2h2, Y(3)2=k1b1X(3)μ1h1, and X(3) is uniquely determined by the following equation:

    a1X2+a2X+a3=0, (3.2)

    where

    a1=b1b2(h1k2+h2k1)<0,a2=μh1h2+μ2b1h1+μ1b2h2+c1h1b2k2+c2h2k1b1,a3=Λh1h2μ2c1h1μ1c2h2.

    If Λ>μ2c1h2+μ1c2h1, then Descartes rule of sign ensures that the above Eq.(3.2) possesses a uniquely positive root. And the feasibility conditions for E3 are simplified as:

    Λ>μ2c1h2+μ1c2h1,X(3)>X(1)andX(3)>X(2).

    (5) E4=(X(4), Y(4)1, 0, Z(4)) with

    X(4)=Λη1+c1η1Y(4)1μ1c3μη1+b1η1Y(4)1k1b1c3,Y(4)1=μ3θ1η1,Z(4)=k1b1X(4)μ1η1.

    The feasibility conditions of E4 are simplified as:

    R3=X(4)X(1)>1.

    (6) E5=(X(5), 0, Y(5)2, Z(5)) with

    X(5)=Λη2+c2η2Y(5)2μ2c3μη2+b2η2Y(5)2k2b2c3,Y(5)2=μ3θ2η2δ,Z(5)=k2b2X(5)μ2η2.

    Considering the biological background, we assume θ2η2>δ is reasonable, and the feasibility conditions for E5 are simplified as:

    R4=X(5)X(2)>1.

    (7) E6=(X(6), Y(6)1, Y(6)2, Z(6)) with

    Y(6)1=k2b2X(6)η2Z(6)μ2h2,Y(6)2=k1b1X(6)η1Z(6)μ1h1,

    Z(6)=(θ1η1h1k2b2+θ2η2h2k1b1δh2k1b1)X(6)+δh2μ1θ1η1h1μ2θ2η2h2μ1μ3h1h2η1(θ1η2h1+θ2η2h2δh2). And X(6) is uniquely determined by the following equation:

    b1X2+b2X+b3=0, (3.3)

    where

    b1=(b1h1η2+b2h2η1)(θ1η1h1k2b2+θ2η2h2k1b1δh2k1b1)b1b2η1(h1k2+h2k1)(θ1η2h1+θ2η2h2δh2),b2=(b1h1η2+b2h2η1)(δh2μ1θ1η1h1μ2θ2η2h2μ1μ3h1h2)+(c3h1h2c1h1η2c2h2η1)(θ1η1h1k2b2+θ2η2h2k1b1δh2k1b1)+η1(θ1η2h1+θ2η2h2δh2)(b1h1μ2+b2h2μ1+c1h1k2b2+c2h2k1b1μh1h2),b3=(c3h1h2c1h1η2c2h2η1)(δh2μ1θ1η1h1μ2θ2η2h2μ1μ3h1h2)+(θ1η2h1+θ2η2h2δh2)(Λh1h2c1h1μ2c2h2μ1),

    If b1b3<0, then Descartes rule of sign ensures that the above Eq.(3.3) possesses a uniquely positive root. The feasibility conditions for E6 are simplified as: Y(6)1,Y(6)2,Z(6)>0,b1b3<0.

    Remark 3.1. (1) The necessary conditions for the existence of E3 are R1>1 and R2>1.

    (2) Because of the complexity of computation, we have not obtain the exact formula of positive equilibrium E6.

    In this subsection we discuss the stability of each equilibrium when τ = 0.

    Obviously, the eigenvalues of the Jacobian matrix of system (1.2) at equilibrium E0 are λ1=μ<0, λ2=μ3<0, λ3=k1b1X(0)μ1, λ4=k2b2X(0)μ2, so we get the following result.

    Theorem 3.2. If R1<1 and R2<1, then the disease-free equilibrium E0 is locally asymptotically stable and it is unstable if R1>1 or R2>1.

    The Jacobian matrix of system (1.2) at equilibrium E1 is

    (μb1Y(1)1b1X(1)+c1b2X(1)+c2c3k1b1Y(1)10h1Y(1)1η1Y(1)100k2b2X(1)h2Y(1)1μ20000θ1η1Y(1)1μ3).

    The characteristic equation at the equilibrium E1 is

    [λ(k2b2X(1)h2Y(1)1μ2)][λ+μ3θ1η1Y(1)1][λ2+(μ+b1Y(1)1)λ+k1b1Y(1)1(b1X(1)c1)]=0. (3.4)

    Thus, we get the following result.

    Theorem 3.3. If 1<R1<X(0)b1c1, R2<R1 and μ3>θ1η1Y(1)1, then the equilibrium E1 is locally asymptotically stable.

    The Jacobian matrix of system (1.2) at equilibrium E2 is

    (μb2Y(2)2b1X(2)+c1b2X(2)+c2c30k1b1X(2)h1Y(2)2μ100k2b2Y(2)2h1Y(2)20η2Y(2)2000θ2η2Y(2)2δY(2)2μ3).

    The characteristic equation at the equilibrium E2 is

    [λ(k1b1X(2)h1Y(2)2μ1)][λ+δY(2)2+μ3θ2η2Y(2)2][λ2+(μ+b2Y(2)2)λ+k2b2Y(2)2(b2X(2)c2)]=0. (3.5)

    So we get the following result.

    Theorem 3.4. If 1<R2<X(0)b2c2, R2>R1 and μ3>(θ2η2f)Y(2)2, then the equilibrium E2 is locally asymptotically stable.

    The Jacobian matrix of system (1.2) at equilibrium E3 is

    (μb1Y(3)1b2Y(3)2b1X(3)+c1b2X(3)+c2c3k1b1Y(3)10h1Y(3)1η1Y(3)1k2b2Y(3)2h2Y(3)20η2Y(3)2000θ1η1Y(3)1+θ2η2Y(3)2δY(3)2μ3),

    with the characteristic equation

    [λ(θ1η1Y(3)1+θ2η2Y(3)2δY(3)2μ3)](λ3+A1λ2+A2λ+A3)=0, (3.6)

    where

    A1=μ+b1Y(3)1+b2Y(3)2,A2=k1b1Y(3)1(b1X(3)c1)+k2b2Y(3)2(b2X(3)c2)h1h2Y(3)1Y(3)2,A3=h1h2Y(3)1Y(3)2(μ+b1Y(3)1+b2Y(3)2)h1k2b2Y(3)1Y(3)2(b1X(3)c1)h2k1b1Y(3)1Y(3)2(b1X(3)c1).

    Denote D(P) denote the discriminant of a polynomial

    Q(λ)=λ3+A1λ2+A2λ+A3. Then

    D(Q)=18A1A2A3+(A1A2)24A3A314A3227A33.

    If μ3>θ1η1Y(3)1+θ2η2Y(3)2δY(3)2, in order to discuss the stability of the equilibrium E3, we get the following result by use of the same method as in Ref [44].

    Proposition 3.5. The equilibrium E3 is asymptotically stable if one of the following conditions holds for polynomial Q and D(Q):

    (1)D(Q)>0,A1>0,A3>0 and A1A2>A3.

    (2)D(Q)<0,A10,A20,A30 and α<23.

    The Jacobian matrix of system (1.2) at equilibrium E4 is

    (m11m12m13m14m210m23m2400m3300m42m43m44),

    where

    m11=μb1Y(4)1,m12=b1X(4)+c1,m13=b2X(4)+c2,m14=c3,m21=k1b1Y(4)1,m23=h1Y(4)1m24=η1Y(4)1,m33=k2b2X(4)η2Z(4)h2Y(4)1μ2,m42=θ1η1Z(4),m43=θ2η2Z(4)δZ(4),m44=θ1η1Y(4)1μ3.

    The characteristic equation at the equilibrium E4 is

    [λ(k2b2X(4)η2Z(4)h2Y(4)1μ2)][λ3+B1λ2+B2λ+B3]=0, (3.7)

    where

    B1=m11m44,B2=m11m44m12m21m24m42,B3=m11m24m42+m12m21m44m14m21m42.

    Denote D(P) denote the discriminant of a polynomial

    Q(λ)=λ3+B1λ2+B2λ+B3. Then

    D(Q)=18B1B2B3+(B1B2)24B3B314B3227B33.

    If μ2>k2b2X(4)η2Z(4)h2Y(4)1, in order to discuss the stability of the equilibrium E4, we get the following result by use of the same method as in Ref [44].

    Proposition 3.6. The equilibrium E4 is asymptotically stable if one of the following conditions holds for polynomial Q and D(Q):

    (1)D(Q)>0,B1>0,B3>0 and B1B2>B3.

    (2)D(Q)<0,B10,B20,B30 and α<23.

    The Jacobian matrix of system (1.2) at equilibrium E5 is

    (ˆm11ˆm12ˆm13ˆm140ˆm2200ˆm31ˆm320ˆm340ˆm42ˆm43ˆm44),

    where

    ˆm11=μb2Y(5)2,ˆm12=b1X(5)+c1,ˆm13=b2X(5)+c2,ˆm14=c3,ˆm22=k1b1X(5)η1Z(5)h1Y(5)2μ1,ˆm31=k2b2Y(5)2ˆm32=h2Y(5)2,ˆm34=η2Y(5)2,ˆm42=θ1η1Z(5),ˆm43=θ2η2Z(5)δZ(5),ˆm44=θ2η2Y(5)2δY(5)2μ3.

    The characteristic equation at the equilibrium E5 is

    [λ(k1b1X(5)η1Z(5)h1Y(5)2μ1)][λ3+C1λ2+C2λ+C3]=0, (3.8)

    where

    C1=ˆm11ˆm44,C2=ˆm11ˆm44ˆm13ˆm31ˆm34ˆm43,C3=ˆm11ˆm34ˆm43+ˆm13ˆm31ˆm44ˆm14ˆm31ˆm43.

    Denote D(P) denote the discriminant of a polynomial

    Q(λ)=λ3+C1λ2+C2λ+C3. Then

    D(Q)=18C1C2C3+(C1C2)24C3C314C3227C33.

    If μ1>k1b1X(5)η1Z(5)h1Y(5)2, in order to discuss the stability of the equilibrium E5, we get the following result by use of the same method as in Ref [44].

    Proposition 3.7. The equilibrium E5 is asymptotically stable if one of the following conditions holds for polynomial Q and D(Q):

    (1)D(Q)>0,C1>0,C3>0 and C1C2>C3.

    (2)D(Q)<0,C10,C20,C30 and α<23.

    Theorem 3.8. The equilibrium E6 is locally asymptotically stable if the following conditions hold:

    (H5) X(6)>max{c1b1, c2b2},

    (H6) k1b1η1<k2b2η2,

    (H7) k3>η2(μ+b1Y(6)1+b2Y(6)2)c3b2,

    (H8) (e1e2e3)e3e4e21>0.

    Proof. The Jacobian matrix of system (1.2) at equilibrium E6 is

    (a11a12a13a14a210a23a24a31a320a340b42a43+b43a44+b44)

    where

    a11=μb1Y(6)1b2Y(6)2,a12=b1X(6)+c1,a13=b2X(6)+c2,a14=c3,a21=k1b1Y(6)1,a23=h1Y(6)1a24=η1Y(6)1,a31=k2b2Y(6)2,a32=h2Y(6)2a34=η2Y(6)2,a43=fZ(6),a44=fY(6)2μ3,b42=θ1η1Z(6),b43=θ2η2Z(6),b44=θ1η1Y(6)1+θ2η2Y(6)2.

    The characteristic equation at the equilibrium E6 is

    λ4+e1λ3+e2λ2+e3λ+e4=0, (3.9)

    where

    e1=a11>0,e2=a13a31a12a21a23a32a34a43a24b42a34b43,e3=a11a23a32a12a23a31a13a21a32+a11a34a43a14a31a43a24a32a43+a11a24b42a14a21b42+a11a34b43a14a31b43a23a34b42a24a32b43,e4=a11a24a32a43+a12a21a34a43a12a24a31a43a14a21a32a43+a11a23a34b42+a11a24a32b43+a12a21a34b43a12a24a31b43a13a21a34b42+a13a24a31b42a14a21a32b43a14a23a31b42.

    By simple calculation, if X(6)>max{c1b1, c2b2}, then e1e2>e3; if k3>η2(μ+b1Y(6)1+b2Y(6)2)c3b2 and k1b1η1<k2b2η2, then e4>0. In summary, the condition of the Routh-Hurwitz criterion above is satisfied for Eq.(3.9), that is,

    e1>0, e1e2>e3, (e1e2e3)e3e4e21>0, e4>0,

    hold. So, all the roots of this Eq.(3.9) have negative real part. This ends the proof.

    Remark 3.9 In Theorem (3.8), (H5)-(H8) is a sufficient condition for equilibrium E6 to be stable, and the necessary and sufficient condition for E6 to be stable is all roots of Eq.(3.9) satisfy |arg(λi)|>απ2.

    In this subsection, according to the research methods in literature [22,38,45], we study the Hopf bifurcation with time delay as the parameter.

    we will analyze the Hopf bifurcation of E6 when τ>0, and the characteristic equation at the equilibrium E6 is

    s4α+p1s3α+p2s2α+p3sα+p4+(q1s3α+q2s2α+q3sα+q4)esτ=0, (3.10)

    where

    p1=a11a44,p2=a11a44a13a31a12a21a23a32a34a43,p3=a11a23a32a12a23a31a13a21a32+a12a21a44+a11a34a43+a13a31a44a14a31a43+a23a32a44a24a32a43,p4=a11a23a32a44+a11a24a32a43+a12a21a34a43+a12a23a31a44a12a24a31a43+a13a21a32a44a14a21a32a43,q1=b44,q2=a11b44a24b42a34b43,q3=a11a24b42+a12a21b44a14a21b42+a11a34b43+a13a31b44a14a31b43+a23a32b44a23a34b42a24a32b43,q4=a11a23a32b44+a11a23a34b42+a11a24a32b43+a12a21a34b43+a12a23a31b44a12a24a31b43+a13a21a32b44a13a21a34b42+a13a24a31b42a14a21a32b43a14a23a31b42.

    Assume that s=iω=ω(cosπ2+isinπ2), ω>0 is a root of Eq.(3.10).

    Substituting s=iω into Eq.(3.10), one gets

    ω4α(cos2απ+isin2απ)+p1ω3α(cos3απ2+isin3απ2)+p2ω2α(cosαπ+isinαπ)+p3ωα(cosαπ2+isinαπ2)+p4+[q1ω3α(cos3απ2+isin3απ2)+q2ω2α(cosαπ+isinαπ)+q3ωα(cosαπ2+isinαπ2)+q4](cosωτisinωτ)=0. (3.11)

    and separating the real and imaginary parts of it, it results in

    {R2cos(ωτ)+I2sin(ωτ)=R1,I2cos(ωτ)R2sin(ωτ)=I1, (3.12)

    Ri,Ii are defined as follows:

    R1=ω4αcos2απ+p1ω3αcos3απ2+p2ω2αcosαπ+p3ωαcosαπ2+p4,R2=q1ω3αcos3απ2+q2ω2αcosαπ+q3ωαcosαπ2+q4,I1=ω4αsin2απ+p1ω3αsin3απ2+p2ω2αsinαπ+p3ωαsinαπ2,I2=q1ω3αsin3απ2+q2ω2αsinαπ+q3ωαsinαπ2.

    It can be acquired from Eq. (3.12) that

    {cos(ωτ)=R1R2+I1I2R22+I22=F(ω),sin(ωτ)=R2I1R1I2R22+I22=G(ω). (3.13)

    Adding the squares of the two equations of Eq.(3.12), we obtain

    ω8α+M+N=0. (3.14)

    where M is a polynomial containing ω7α, ω6α, ω5α, ω4α, ω3α, ω2α, ωα, and N is a constant.

    Define

    h(ω)=ω8α+M+N. (3.15)

    Suppose that N<0. Thus, h(ω) has at least one positive root. The delay τ is regarded as a bifurcation parameter. Let s(ω)=ξ(τ)+iω(τ) be the Eq.(3.10) such that for some initial value of the bifurcation parameter τ0 we have ξ(τ0)=0, ω(τ0)=ω0. Without loss of generality, we assume ω(0)>0. From Eq.(3.13), one can conclude

    τj=1ω0[arccosF(ω)+2jπ],j=0, 1, 2. (3.16)

    where

    τ0=min{τj},j=0, 1, 2.

    To derive the condition of the occurrence for Hopf bifurcation, we have the following Lemma.

    Lemma 3.10. Assume that N<0, then Hopf bifurcation occurs provided h(ω0)0.

    Proof. Differentiating both sides of Eq.(3.10) with respect to τ, it can be obtained that

    (4αs4α1+3αp1s3α1+2αp2s2α1+αp3sα1)dsdτ+(3αq1s3α1+2αq2s2α1+αq3sα1)esτdsdτ+(q1s3α+q2s2α+q3sα+q4)esτ(τdsdτs)=0.

    Hence, one gets

    (dsdτ)1=(4αs4α1+3αp1s3α1+2αp2s2α1+αp3sα1)+(3αq1s3α1+2αq2s2α1+αq3sα1)esτs(q1s3α+q2s2α+q3sα+q4)esττs(4αs4α1+3αp1s3α1+2αp2s2α1+αp3sα1)s(s4α+p1s3α+p2s2α+p3sα+p4)+(3αq1s3α1+2αq2s2α1+αq3sα1)s(q1s3α+q2s2α+q3sα+q4)τs. (3.17)

    Substitute s=iω0 into Eq.(3.17), we have

    Re[(dsdτ)1|τ=τ0]=Re[(4α(iω0)4α1+3αp1(iω0)3α1+2αp2(iω0)2α1+αp3(iω0)α1)(iω0)((iω0)4α+p1(iω0)3α+p2(iω0)2α+p3(iω0)α+p4)+(3αq1(iω0)3α1+2αq2(iω0)2α1+αq3(iω0)α1)(iω0)(q1(iω0)3α+q2(iω0)2α+q3(iω0)α+q4)]=Re[(4α(iω0)4α1+3αp1(iω0)3α1+2αp2(iω0)2α1+αp3(iω0)α1)(iω0)((iω0)4α+p1(iω0)3α+p2(iω0)2α+p3(iω0)α+p4)+(3αq1(iω0)3α1+2αq2(iω0)2α1+αq3(iω0)α1)(iω0)(q1(iω0)3α+q2(iω0)2α+q3(iω0)α+q4)]=h(ω0)2ω0G,

    where

    G=(q1ω3α0cos(3α+1)π2+q2ω2α0cos(2α+1)π2+q3ωα0cos(α+1)π2)2+(q1ω3α0sin(3α+1)π2+q2ω2α0sin(2α+1)π2+q3ωα0sin(α+1)π2+q4)2.

    then sign{dRe(λ)dτ|τ=τ0}=sign{Re[(dλdτ)1|τ=τ0]}=sign{h(ω0)}.

    Obviously, if h(ω0)0 the transversality condition holds, and Hopf bifurcation occurs at τ=τ0.

    Theorem 3.11. Suppose that (H5)-(H8) and N<0 hold, then the positive equilibrium E6 of system (1.2) is asymptotically stable when τ[0,τ0), h(ω0)<0 and unstable when τ>τ0, h(ω0)>0. When τ=τ0, h(ω0)0 a Hopf bifurcation occurs, that is a family of periodic solutions bifurcates from E6 as τ passes through the critical value τ0.

    In this section, some numerical examples are presented to verify the theoretical results. The simulation are based on Adama-Bashforth-Moulton predictor-corrector scheme [46].

    Example 1. For the following set of parameters: Λ= 1, b1= 0.3, b2= 0.25, c1= 0.06, c2= 0.06, c3= 0.06, k1= 0.7, k2= 0.7, η1= 2.1, η2= 0.2, μ= 1, μ1= 0.5, μ2= 0.3, μ3= 0.3, θ1= 0.6, θ2= 0.7, δ= 0.1, h1= 0.2, h2= 0.1.

    In this case R1=0.42<1, R2=0.5833<1. From Figure 1, we can see that the equilibrium E0=(1, 0, 0, 0) is stable for different values of α and different sets of initial values: [X(0), Y1(0), Y2(0), Z(0)]=[0.9, 0.2, 0.2, 0.2], [1.2, 0.5, 0.3, 0.6].

    Figure 1.  (a)-(d) are the time series of the system (1.2), which show that the equilibrium E0 is stable for different values of α (α = 1, 0.9) when τ = 0; the red and and the blue and .. line represents dynamics with initial value [0.9, 0.2, 0.2, 0.2]; the yellow and ... and the green and line represents dynamics with initial value [1.2, 0.5, 0.3, 0.6].

    Example 2. For the following set of parameters: Λ= 0.5, b1= 2.5, b2= 0.3, c1= 0.01, c2= 0.01, c3= 0.06, k1= 0.5, k2= 0.7, η1= 0.2, η2= 2.1, μ= 1, μ1= 0.3, μ2= 0.5, μ3= 0.3, θ1= 0.5, θ2= 0.1, δ= 0.01, h1= 0.2, h2= 0.1.

    In this case, 1<R1=2.0833<X(0)b1c1, R2=0.21<R1 and μ3>θ1η1Y(1)1. From Figure 2, we can see that the equilibrium E1=(0.24, 0.4407, 0, 0) is stable for different values of α and different sets of initial values: [X(0), Y1(0), Y2(0), Z(0)]=[0.1,0.6, 0.5, 0.2], [0.2,0.5, 0.8, 0.6].

    Figure 2.  (a)-(d) are the time series of the system (1.2), which show that the equilibrium E1 is stable for different values of α (α = 1, 0.9) when τ = 0; the red and and the blue and .. line represents dynamics with initial value [0.1, 0.6, 0.5, 0.2]; the yellow and ... and the green and line represents dynamics with initial value [0.2, 0.5, 0.8, 0.6].

    Example 3. For the following set of parameters: Λ= 0.5, b1= 0.3, b2= 2.5, c1= 0.01, c2= 0.01, c3= 0.06, k1= 0.5, k2= 0.6, η1= 2.1, η2= 0.2, μ= 1, μ1= 0.3, μ2= 0.5, μ3= 0.5, θ1= 0.1, θ2= 0.1, δ= 0.01, h1= 0.2, h2= 0.1.

    In this case, 1<R2=1.5<X(0)b2c2, R2>R1 and μ3>(θ2η2f)Y(2)2. From Figure 3, we can see that the equilibrium E2=(0.3333, 0, 0.2024, 0) is stable for different values of α and different sets of initial values: [X(0), Y1(0), Y2(0), Z(0)]=[0.2, 0.1, 0.5, 0.2], [0.1, 0.05, 0.3, 0.6].

    Figure 3.  (a)-(d) are the time series of the system (1.2), which show that the equilibrium E2 is stable for different values of α (α = 1, 0.9) when τ = 0; the red and and the blue and .. line represents dynamics with initial value [0.2, 0.1, 0.5, 0.2]; the yellow and ... and the green and line represents dynamics with initial value [0.1, 0.05, 0.3, 0.6].

    Remark 4.1. The above three examples corresponding to the following ecological interpretation.

    (1) Figure 1 indicates that if R1<1, R2<1, then the phytoplankton can not survive and the zooplankton will also die out. However, this phenomenon usually does not happen in the real world.

    (2) Figure 2 indicates that if R1>1, R1>R2, then the non-toxic phytoplankton will win the competition between phytoplankton and toxic phytoplankton, while the zooplankton will die out due to excessive mortality.

    (3) Figure 3 indicates that if R2>1, R2>R1, then the toxic phytoplankton will win the competition between phytoplankton and toxic phytoplankton, while the zooplankton will die out due to excessive mortality.

    Example 4. For the following set of parameters: Λ= 1.4, b1= 2.8, b2= 2.3, c1= 0.01, c2= 0.01, c3= 0.06, k1= 0.95, k2= 0.1, η1= 2.1, η2= 0.26, μ= 0.2, μ1= 0.2, μ2= 0.8, μ3= 0.5, θ1= 0.2, θ2= 0.5, δ= 0.01, h1= 0.1, h2= 0.1.

    In this case, simple calculation indicates that the sufficient condition (2) of Proposition 3.6 is satisfied. From Figure 4 we can see that the equilibrium E4=(0.4067, 1.1905, 0, 0.4199) is stable for different values of α and different sets of initial values: [X(0), Y1(0), Y2(0), Z(0)]=[0.2, 0.3, 0.5, 0.2], [0.3, 0.4, 0.8, 0.6].

    Figure 4.  (a)-(d) are the time series of the system (1.2), which show that the equilibrium E4 is stable for different values of α (α = 1, 0.95) when τ = 0; the red and and the blue and .. line represents dynamics with initial value [0.2, 0.3, 0.5, 0.2]; the yellow and ... and the green and line represents dynamics with initial value [0.3, 0.4, 0.8, 0.6].

    Example 5. For the following set of parameters: Λ= 1.4, b1= 2.3, b2= 2.5, c1= 0.01, c2= 0.01, c3= 0.06, k1= 0.1, k2= 0.95, η1= 0.26, η2= 2.1, μ= 0.2, μ1= 0.8, μ2= 0.2, μ3= 0.5, θ1= 0.5, θ2= 0.2, δ= 0.01, h1= 0.1, h2= 0.1.

    In this case, simple calculation indicates that the sufficient condition (2) of Proposition 3.7 is satisfied. From Figure 5 we can see that the equilibrium E5=(0.4422, 0, 1.2195, 0.4048) is stable for different values of α and different sets of initial values: [X(0), Y1(0), Y2(0), Z(0)]=[0.2, 0.5, 0.3, 0.2], [0.3, 0.8, 0.4, 0.6].

    Figure 5.  (a)-(d) are the time series of the system (1.2), which show that the equilibrium E5 is stable for different values of α (α = 1, 0.8) when τ = 0; the red and and the blue and .. line represents dynamics with initial value [0.2, 0.5, 0.3, 0.2]; the yellow and ... and the green and line represents dynamics with initial value [0.3, 0.8, 0.4, 0.6].

    Remark 4.2. The above examples corresponding to the following ecological interpretation.

    (1) Figure 4 indicates that if the toxic phytoplankton is less competitive than the non-toxic phytoplankton, then the toxic phytoplankton will die out.

    (2) Figure 5 indicates that if the toxic phytoplankton win the competition between non-toxic phytoplankton and toxic phytoplankton, then the zooplankton may still survive under certain conditions, that is, nutrients, toxic phytoplankton and zooplankton may theoretically coexist. However, this phenomenon usually does not appear in real world.

    (3) From Figures 15 we can see that as the value of α decreases, the steady speed becomes slow for each equilibrium. This indicates that the value of α has obvious effects on the dynamical behaviors of the system.

    Example 6. For the following set of parameters: α= 0.8, Λ= 1.4, b1= 0.32, b2= 0.54, c1= 0.06, c2= 0.08, c3= 0.6, k1= 0.7, k2= 0.6, η1= 1.8, η2= 0.6, μ= 0.2, μ1= 0.4, μ2= 0.9, μ3= 0.5, θ2= 0.5, δ= 0.1, h1= 0.1, h2= 0.1.

    In this example, we will consider the influence of toxic, i.e., θ1. Here, we choose θ1=0,0.6, with the initial conditions: [X(0), Y1(0), Y2(0), Z(0)] = [0.2, 0.2, 0.3, 0.2], [0.8, 0.8, 0.6, 0.8].

    Example 7. In this example, we will consider the influence of α.

    (1) For the following set of parameters: Λ= 1.4, b1= 2.3, b2= 2.5, c1= 0.01, c2= 0.01, c3= 0.06, k1= 0.1, k2= 0.95, η1= 0.26, η2= 2.1, μ= 0.2, μ1= 0.8, μ2= 0.2, μ3= 0.5, θ1= 0.5, θ2= 0.2, δ= 0.01, h1= 0.1, h2= 0.1, with the initial conditions: [X(0), Y1(0), Y2(0), Z(0)] = [0.2, 0.5, 0.3, 0.2].

    (2) For the following set of parameters: Λ= 1.4, b1= 0.32, b2= 0.54, c1= 0.06, c2= 0.08, c3= 0.6, k1= 0.7, k2= 0.6, η1= 1.8, η2= 0.6, μ= 0.2, μ1= 0.4, μ2= 0.9, μ3= 0.5, θ1= 0.6, θ2= 0.5, δ= 0.1, h1= 0.1, h2= 0.1, with the initial conditions: [X(0), Y1(0), Y2(0), Z(0)] = [0.5, 0.5, 0.5, 0.2].

    Remark 4.3. (1) From Figure 7, we can see that if the value of α is relatively big(i.e., α = 1, 0.8), then the equilibrium E5 is locally stable; if the value of α is relatively small(i.e., α = 0.4), then the equilibrium is unstable, and oscillation may occur.

    Figure 7.  (a)-(d) are the time series of the system (1.2), which show the influence of α. (The initial conditions: [0.2, 0.5, 0.3, 0.2]).

    (2) From Figure 8, we can see that if the value of α is relatively big(i.e., α = 1, 0.7), then the equilibrium E6 is locally stable; if the value of α is relatively small(i.e., α = 0.1), then the equilibrium E0 is locally stable.

    Figure 8.  (a)-(d) are the time series of the system (1.2), which show the influence of α. (The initial conditions: [0.5, 0.5, 0.5, 0.2]).

    (3) Figure 7 and Figure 8 indicate that if the value of α is relatively small, the system will be destabilized.

    Example 8. For the following set of parameters: α= 0.89, Λ= 1.4, b1= 0.32, b2= 0.54, c1= 0.06, c2= 0.08, c3= 0.6, k1= 0.7, k2= 0.6, η1= 1.8, η2= 0.6, μ= 0.2, μ1= 0.4, μ2= 0.9, μ3= 0.5, θ1= 0.6, θ2= 0.5, δ= 0.1, h1= 0.1, h2= 0.1.

    In this example, the equilibrium E6=(3.2026, 0.4114, 0.2784, 0.1608), and our main aim is to study the effect of time delay on the stability of the system.

    (1) From Figure 9, we can see that if τ=0, then the equilibrium E6 is stable with different sets of initial value: [X(0), Y1(0), Y2(0), Z(0)]=[0.5, 0.5, 0.5, 0.2], [2.8, 1.8, 3.3, 1.3].

    Figure 9.  (a)-(d) are the time series of the system (1.2), which show that the equilibrium E6 is stable for α= 0.89 and τ=0, the blue and line represents dynamics with initial value [0.5, 0.5, 0.5, 0.2];the red and .. line represents dynamics with initial value [0.8, 0.8, 0.3, 0.3].

    (2) From Figure 10, we will see that if τ=3<τ04.4671, then the equilibrium E6 is stable with different sets of initial value: [X(0), Y1(0), Y2(0), Z(0)]=[0.5, 0.5, 0.5, 0.2], [2.8, 1.8, 3.3, 1.3].

    Figure 10.  (a)-(d) are the time series of the system (1.2), which show that the equilibrium E6 is stable for α= 0.89 and τ=3<τ04.4671, the blue and line represents dynamics with initial value [0.5, 0.5, 0.5, 0.2];the red and .. line represents dynamics with initial value [0.8, 0.8, 0.3, 0.3].

    (3) From Figure 11, we can see that if τ=4.2<τ04.4671, then the equilibrium E6 is stable with different sets of initial value: [X(0), Y1(0), Y2(0), Z(0)]=[0.5, 0.5, 0.5, 0.2], [2.8, 1.8, 3.3, 1.3].

    Figure 11.  (a)-(d) are the time series of the system (1.2), which show that the equilibrium E6 is stable for α= 0.89 and τ=4.2<τ04.4671, the blue and line represents dynamics with initial value [0.5, 0.5, 0.5, 0.2];the red and .. line represents dynamics with initial value [0.8, 0.8, 0.3, 0.3].

    (4) From Figure 12, we will see that if τ=5>τ04.4671, then periodic oscillation occurs, and the equilibrium E6 will lose its stability and periodic solutions appear through Hopf bifurcation, with different sets of initial value: [X(0), Y1(0), Y2(0), Z(0)]=[0.5, 0.5, 0.5, 0.2], [0.8, 0.8, 0.3, 0.3].

    Figure 12.  (a)-(d) are time series of the system (1.2), which show that the equilibrium E6 is unstable, and periodic oscillation occurs, for α= 0.89 and τ=5>τ04.4671. The blue and line represents the dynamics with initial value [0.5, 0.5, 0.5, 0.2]; while the red and .. line represents the dynamics with initial value [0.8, 0.8, 0.3, 0.3].

    (5) From Figure 13, we can see that if τ=6>τ04.4671, then similar periodic oscillation occurs as that in Figure 12, but with larger amplitude.

    Figure 13.  (a)-(d) are the time series of the system (1.2), which show that the equilibrium E6 is unstable, and periodic oscillation occurs, for α= 0.89 and τ=6>τ04.4671. The blue and line represents the dynamics with initial value [0.5, 0.5, 0.5, 0.2]; while the red and .. line represents the dynamics with initial value [0.8, 0.8, 0.3, 0.3].

    Remark 4.4. From the above example, we can see that the time delay has an effect of destabilizing the equilibrium E6. In other words, the larger the value of time delay is, the more possible that the equilibrium E6 lose its stability.

    In this paper, a fractional-order mathematical model is constructed to describe the active of nutrient-phytoplankton-toxic phytoplankton-zooplankton.

    Through qualitative analysis, we get the following results.

    We figure out the sufficient conditions for the existence and local stability of E0, E1, E2, E3, E4, E5, E6 for τ=0.

    By using time delay as a bifurcation parameter, the existence of Hopf bifurcation is analyzed in detail. We find that if τ<τ0, then the equilibrium E6 is locally stable; while it is unstable if τ>τ0 and Hopf bifurcation may occur near τ0.

    Through numerical simulation we get the following results.

    Figure 1 shows the stability of equilibrium E0 for different values of α.

    Figure 2 shows the stability of equilibrium E1 for different values of α.

    Figure 3 shows the stability of equilibrium E2 for different values of α.

    Figure 4 shows the stability of equilibrium E4 for different values of α.

    Figure 5 shows the stability of equilibrium E5 for different values of α.

    Figure 6 shows the effect of parameter θ1 on the system (1.2).

    Figure 6.  (a)-(d) are the time series of the system (1.2), which show the influence of θ1. (The initial conditions: [0.2, 0.2, 0.3, 0.2], [0.8, 0.8, 0.6, 0.8]).

    Figure 7 and Figure 8 indicate that the value of α is closely relate to the stability of each equilibrium. The stability of each equilibrium becomes weaker as the value of α decreases.

    Figures 911 show that E6 is stable if τ[0,τ0); Figures 1213 show that E6 is unstable if τ>τ0 and periodic oscillation may occur; Figures 913 indicate that the impact of τ on the dynamics of the system is crucial.

    Table 2 and Figure 14 show that the value of τ0 arises as the value of α increases.

    Table 2.  The effect of α on the values ω0, τ0 in system(1.2).
    Fractional order α Critical frequency ω0 Bifurcation point τ0
    0.60 0.0221 49.8601
    0.65 0.0318 30.9419
    0.70 0.0436 20.0341
    0.75 0.0576 13.3431
    0.80 0.0740 8.9972
    0.85 0.0927 6.1119
    0.90 0.1140 4.1175
    0.95 0.1378 2.7095
    1.00 0.1642 1.6926

     | Show Table
    DownLoad: CSV
    Figure 14.  Illustration of bifurcation τ0 versus fractional order α for system (1.2). The bifurcation points are becoming smaller and smaller as the value of α increase.

    Remark 5.1. When τ=0, Y1=Y2 and h1=h2=0, then system (1.2) will degenerated to the model in [40].

    In the model of this paper, phytoplankton is divided into two class, non-toxic phytoplankton and toxic phytoplankton. Some experimental data suggested that some zooplankton are capable of selecting for nontoxic phytoplankton, a mechanism that allows toxic phytoplankton to coexist with nontoxic phytoplankton [47]. This is also consistent with the results in Figure 9. Although some zooplankton have the ability to distinguish between toxic and non-toxic plants, some other experiments have shown that some zooplankton might not be able to distinguish between toxic and nontoxic algae, even shows a slight preference for toxic strains [48,49]. We can find from Figure 6 that once non-toxic phytoplankton become scarce, the zooplankton start to eat the toxic phytoplankton, even if the toxicity is weak, the zooplankton may become extinct. This is dangerous for the ecosystem.

    Remark 5.2. Any ecosystem depends on the natural environment, and in the real natural environment there are more or less physical and chemical signals that interact with the ecosystem. This motivate us to consider stochastic effects to the ecosystem, that is, white noise should be included into the system. We leave this as our next work.

    Each of the authors, Ruiqing Shi, Jianing Ren, Cuihong Wang contributed to each part of this work equally and read and approved the final version of the manuscript.

    This work is partly supported by National Natural Science Foundation of China (No. 61907027). The authors would like to thank the anonymous reviewers for their helpful comments, which improved the quality of this paper greatly.

    The authors declare that they have no financial or non-financial competing interests.

    [1] Hamblin MR (2017) History of Low-Level Laser (Light) Therapy, In: Hamblin MR, de Sousa MVP, Agrawal T, Editors, Handbook of Low-Level Laser Therapy, Singapore: Pan Stanford Publishing.
    [2] Anders JJ, Lanzafame RJ, Arany PR (2015) Low-level light/laser therapy versus photobiomodulation therapy. Photomed Laser Surg 33: 183–184. doi: 10.1089/pho.2015.9848
    [3] Hamblin MR, de Sousa MVP, Agrawal T (2017) Handbook of Low-Level Laser Therapy, Singapore: Pan Stanford Publishing.
    [4] de Freitas LF, Hamblin MR (2016) Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron 22: 348–364. doi: 10.1109/JSTQE.2016.2561201
    [5] Wang Y, Huang YY, Wang Y, et al. (2016) Photobiomodulation (blue and green light) encourages osteoblastic-differentiation of human adipose-derived stem cells: role of intracellular calcium and light-gated ion channels. Sci Rep 6: 33719. doi: 10.1038/srep33719
    [6] Wang L, Jacques SL, Zheng L (1995) MCML-Monte Carlo modeling of light transport in multi-layered tissues. Comput Meth Prog Bio 47: 131–146. doi: 10.1016/0169-2607(95)01640-F
    [7] Huang YY, Chen AC, Carroll JD, et al. (2009) Biphasic dose response in low level light therapy. Dose Response 7: 358–383.
    [8] Huang YY, Sharma SK, Carroll JD, et al. (2011) Biphasic dose response in low level light therapy-an update. Dose Response 9: 602–618. doi: 10.2203/dose-response.11-009.Hamblin
    [9] Mason MG, Nicholls P, Cooper CE (2014) Re-evaluation of the near infrared spectra of mitochondrial cytochrome c oxidase: Implications for non invasive in vivo monitoring of tissues. Biochim Biophys Acta 1837: 1882–1891. doi: 10.1016/j.bbabio.2014.08.005
    [10] Karu TI, Pyatibrat LV, Kolyakov SF, et al. (2005) Absorption measurements of a cell monolayer relevant to phototherapy: reduction of cytochrome c oxidase under near IR radiation. J Photochem Photobiol B 81: 98–106. doi: 10.1016/j.jphotobiol.2005.07.002
    [11] Karu TI (2010) Multiple roles of cytochrome c oxidase in mammalian cells under action of red and IR-A radiation. IUBMB Life 62: 607–610. doi: 10.1002/iub.359
    [12] Wong-Riley MT, Liang HL, Eells JT, et al. (2005) Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: role of cytochrome c oxidase. J Biol Chem 280: 4761–4771. doi: 10.1074/jbc.M409650200
    [13] Lane N (2006) Cell biology: power games. Nature 443: 901–903. doi: 10.1038/443901a
    [14] Pannala VR, Camara AK, Dash RK (2016) Modeling the detailed kinetics of mitochondrial cytochrome c oxidase: Catalytic mechanism and nitric oxide inhibition. J Appl Physiol 121: 1196–1207. doi: 10.1152/japplphysiol.00524.2016
    [15] Fernandes AM, Fero K, Driever W, et al. (2013) Enlightening the brain: linking deep brain photoreception with behavior and physiology. Bioessays 35: 775–779. doi: 10.1002/bies.201300034
    [16] Poletini MO, Moraes MN, Ramos BC, et al. (2015) TRP channels: a missing bond in the entrainment mechanism of peripheral clocks throughout evolution. Temperature 2: 522–534. doi: 10.1080/23328940.2015.1115803
    [17] Caterina MJ, Pang Z (2016) TRP channels in skin biology and pathophysiology. Pharmaceuticals 9: 77. doi: 10.3390/ph9040077
    [18] Montell C (2011) The history of TRP channels, a commentary and reflection. Pflugers Arch 461: 499–506. doi: 10.1007/s00424-010-0920-3
    [19] Smani T, Shapovalov G, Skryma R, et al. (2015) Functional and physiopathological implications of TRP channels. Biochim Biophys Acta 1853: 1772–1782. doi: 10.1016/j.bbamcr.2015.04.016
    [20] Cronin MA, Lieu MH, Tsunoda S (2006) Two stages of light-dependent TRPL-channel translocation in Drosophila photoreceptors. J Cell Sci 119: 2935–2944. doi: 10.1242/jcs.03049
    [21] Sancar A (2000) Cryptochrome: the second photoactive pigment in the eye and its role in circadian photoreception. Annu Rev Biochem 69: 31–67. doi: 10.1146/annurev.biochem.69.1.31
    [22] Weber S (2005) Light-driven enzymatic catalysis of DNA repair: a review of recent biophysical studies on photolyase. Biochim Biophys Acta 1707: 1–23. doi: 10.1016/j.bbabio.2004.02.010
    [23] Gillette MU, Tischkau SA (1999) Suprachiasmatic nucleus: the brain's circadian clock. Recent Prog Horm Res 54: 33–58.
    [24] Kofuji P, Mure LS, Massman LJ, et al. (2016) Intrinsically photosensitive petinal ganglion cells (ipRGCs) are necessary for light entrainment of peripheral clocks. PLoS One 11: e0168651. doi: 10.1371/journal.pone.0168651
    [25] Sexton T, Buhr E, Van Gelder RN (2012) Melanopsin and mechanisms of non-visual ocular photoreception. J Biol Chem 287: 1649–1656. doi: 10.1074/jbc.R111.301226
    [26] Ho MW (2015) Illuminating water and life: Emilio Del Giudice. Electromagn Biol Med 34: 113–122. doi: 10.3109/15368378.2015.1036079
    [27] Inoue S, Kabaya M (1989) Biological activities caused by far-infrared radiation. Int J Biometeorol 33: 145–150. doi: 10.1007/BF01084598
    [28] Damodaran S (2015) Water at biological phase boundaries: its role in interfacial activation of enzymes and metabolic pathways. Subcell Biochem 71: 233–261. doi: 10.1007/978-3-319-19060-0_10
    [29] Chai B, Yoo H, Pollack GH (2009) Effect of radiant energy on near-surface water. J Phys Chem B 113: 13953–13958.
    [30] Pollack GH, Figueroa X, Zhao Q (2009) Molecules, water, and radiant energy: new clues for the origin of life. Int J Mol Sci 10: 1419–1429. doi: 10.3390/ijms10041419
    [31] Sommer AP, Haddad M, Fecht HJ (2015) Light effect on water viscosity: implication for ATP biosynthesis. Sci Rep 5: 12029. doi: 10.1038/srep12029
    [32] FDA (2016) Code of Federal Regulations 21CFR890.5500, Title 21, Vol 8.
    [33] Chen ACH, Huang YY, Arany PR, et al. (2009) Role of reactive oxygen species in low level light therapy. Proc SPIE 7165: 716502–716511. doi: 10.1117/12.814890
    [34] Chen AC, Arany PR, Huang YY, et al. (2011) Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embryonic fibroblasts. PLoS One 6: e22453. doi: 10.1371/journal.pone.0022453
    [35] Sharma SK, Kharkwal GB, Sajo M, et al. (2011) Dose response effects of 810 nm laser light on mouse primary cortical neurons. Lasers Surg Med 43: 851–859. doi: 10.1002/lsm.21100
    [36] Tatmatsu-Rocha JC, Ferraresi C, Hamblin MR, et al. (2016) Low-level laser therapy (904 nm) can increase collagen and reduce oxidative and nitrosative stress in diabetic wounded mouse skin. J Photochem Photobiol B 164: 96–102. doi: 10.1016/j.jphotobiol.2016.09.017
    [37] De Marchi T, Leal Junior EC, Bortoli C, et al. (2012) Low-level laser therapy (LLLT) in human progressive-intensity running: effects on exercise performance, skeletal muscle status, and oxidative stress. Lasers Med Sci 27: 231–236. doi: 10.1007/s10103-011-0955-5
    [38] Fillipin LI, Mauriz JL, Vedovelli K, et al. (2005) Low-level laser therapy (LLLT) prevents oxidative stress and reduces fibrosis in rat traumatized Achilles tendon. Lasers Surg Med 37: 293–300. doi: 10.1002/lsm.20225
    [39] Huang YY, Nagata K, Tedford CE, et al. (2013) Low-level laser therapy (LLLT) reduces oxidative stress in primary cortical neurons in vitro. J Biophotonics 6: 829–838.
    [40] Hervouet E, Cizkova A, Demont J, et al. (2008) HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis 29: 1528–1537. doi: 10.1093/carcin/bgn125
    [41] Madungwe NB, Zilberstein NF, Feng Y, et al. (2016) Critical role of mitochondrial ROS is dependent on their site of production on the electron transport chain in ischemic heart. Am J Cardiovasc Dis 6: 93–108.
    [42] Martins DF, Turnes BL, Cidral-Filho FJ, et al. (2016) Light-emitting diode therapy reduces persistent inflammatory pain: Role of interleukin 10 and antioxidant enzymes. Neuroscience 324: 485–495. doi: 10.1016/j.neuroscience.2016.03.035
    [43] Macedo AB, Moraes LH, Mizobuti DS, et al. (2015) Low-level laser therapy (LLLT) in dystrophin-deficient muscle cells: effects on regeneration capacity, inflammation response and oxidative stress. PLoS One 10: e0128567. doi: 10.1371/journal.pone.0128567
    [44] Chen AC, Huang YY, Sharma SK, et al. (2011) Effects of 810-nm laser on murine bone-marrow-derived dendritic cells. Photomed Laser Surg 29: 383–389. doi: 10.1089/pho.2010.2837
    [45] Yamaura M, Yao M, Yaroslavsky I, et al. (2009) Low level light effects on inflammatory cytokine production by rheumatoid arthritis synoviocytes. Lasers Surg Med 41: 282–290. doi: 10.1002/lsm.20766
    [46] Hwang MH, Shin JH, Kim KS, et al. (2015) Low level light therapy modulates inflammatory mediators secreted by human annulus fibrosus cells during intervertebral disc degeneration in vitro. Photochem Photobiol 91: 403–410. doi: 10.1111/php.12415
    [47] Imaoka A, Zhang L, Kuboyama N, et al. (2014) Reduction of IL-20 expression in rheumatoid arthritis by linear polarized infrared light irradiation. Laser Ther 23: 109–114. doi: 10.5978/islsm.14-OR-08
    [48] Lim W, Choi H, Kim J, et al. (2015) Anti-inflammatory effect of 635 nm irradiations on in vitro direct/indirect irradiation model. J Oral Pathol Med 44: 94–102. doi: 10.1111/jop.12204
    [49] Choi H, Lim W, Kim I, et al. (2012) Inflammatory cytokines are suppressed by light-emitting diode irradiation of P. gingivalis LPS-treated human gingival fibroblasts: inflammatory cytokine changes by LED irradiation. Lasers Med Sci 27: 459–467.
    [50] Sakurai Y, Yamaguchi M, Abiko Y (2000) Inhibitory effect of low-level laser irradiation on LPS-stimulated prostaglandin E2 production and cyclooxygenase-2 in human gingival fibroblasts. Eur J Oral Sci 108: 29–34. doi: 10.1034/j.1600-0722.2000.00783.x
    [51] Nomura K, Yamaguchi M, Abiko Y (2001) Inhibition of interleukin-1beta production and gene expression in human gingival fibroblasts by low-energy laser irradiation. Lasers Med Sci 16: 218–223. doi: 10.1007/PL00011358
    [52] Briken V, Mosser DM (2011) Editorial: switching on arginase in M2 macrophages. J Leukoc Biol 90: 839–841. doi: 10.1189/jlb.0411203
    [53] Whyte CS, Bishop ET, Ruckerl D, et al. (2011) Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc Biol 90: 845–854. doi: 10.1189/jlb.1110644
    [54] Xu H, Wang Z, Li J, et al. (2017) The polarization states of microglia in TBI: A new paradigm for pharmacological intervention. Neural Plast 2017: 5405104.
    [55] Lu J, Xie L, Liu C, et al. (2017) PTEN/PI3k/AKT regulates macrophage polarization in emphysematous mice. Scand J Immunol.
    [56] Saha B, Kodys K, Szabo G (2016) Hepatitis C virus-induced monocyte differentiation into polarized M2 macrophages promotes stellate cell activation via TGF-beta. Cell Mol Gastroenterol Hepatol 2: 302–316. doi: 10.1016/j.jcmgh.2015.12.005
    [57] Fernandes KP, Souza NH, Mesquita-Ferrari RA, et al. (2015) Photobiomodulation with 660-nm and 780-nm laser on activated J774 macrophage-like cells: Effect on M1 inflammatory markers. J Photochem Photobiol B 153: 344–351.
    [58] Silva IH, de Andrade SC, de Faria AB, et al. (2016) Increase in the nitric oxide release without changes in cell viability of macrophages after laser therapy with 660 and 808 nm lasers. Lasers Med Sci 31: 1855–1862. doi: 10.1007/s10103-016-2061-1
    [59] von Leden RE, Cooney SJ, Ferrara TM, et al. (2013) 808 nm wavelength light induces a dose-dependent alteration in microglial polarization and resultant microglial induced neurite growth. Lasers Surg Med 45: 253–263. doi: 10.1002/lsm.22133
    [60] Sousa KB, de Santana Araujo L, Pedroso NM, et al. (2017) Photobiomodulation effects on gene and protein expression of proinflammatory chemokines and cytokines by J774 macrophages polarized to M1 phenotype. Lasers Surg Med 49: 36.
    [61] de Lima FJ, de Oliveira Neto OB, Barbosa FT, et al. (2016) Is there a protocol in experimental skin wounds in rats using low-level diode laser therapy (LLDLT) combining or not red and infrared wavelengths? Systematic review. Lasers Med Sci 31: 779–787.
    [62] Tchanque-Fossuo CN, Ho D, Dahle SE, et al. (2016) Low-level light therapy for treatment of diabetic foot ulcer: a review of clinical experiences. J Drugs Dermatol 15: 843–848.
    [63] Gupta A, Keshri GK, Yadav A, et al. (2015) Superpulsed (Ga-As, 904 nm) low-level laser therapy (LLLT) attenuates inflammatory response and enhances healing of burn wounds. J Biophotonics 8: 489–501. doi: 10.1002/jbio.201400058
    [64] Weylandt KH, Chiu CY, Gomolka B, et al. (2012) Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostag Oth Lipid M 97: 73–82. doi: 10.1016/j.prostaglandins.2012.01.005
    [65] Tang Y, Zhang MJ, Hellmann J, et al. (2013) Proresolution therapy for the treatment of delayed healing of diabetic wounds. Diabetes 62: 618–627. doi: 10.2337/db12-0684
    [66] Bohr S, Patel SJ, Sarin D, et al. (2013) Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model. Wound Repair Regen 21: 35–43. doi: 10.1111/j.1524-475X.2012.00853.x
    [67] Castano AP, Dai T, Yaroslavsky I, et al. (2007) Low-level laser therapy for zymosan-induced arthritis in rats: Importance of illumination time. Lasers Surg Med 39: 543–550. doi: 10.1002/lsm.20516
    [68] Moriyama Y, Moriyama EH, Blackmore K, et al. (2005) In vivo study of the inflammatory modulating effects of low-level laser therapy on iNOS expression using bioluminescence imaging. Photochem Photobiol 81: 1351–1355. doi: 10.1562/2005-02-28-RA-450
    [69] Pallotta RC, Bjordal JM, Frigo L, et al. (2012) Infrared (810-nm) low-level laser therapy on rat experimental knee inflammation. Lasers Med Sci 27: 71–78. doi: 10.1007/s10103-011-0906-1
    [70] Ferraresi C, Hamblin MR, Parizotto NA (2012) Low-level laser (light) therapy (LLLT) on muscle tissue: performance, fatigue and repair benefited by the power of light. Photonics Lasers Med 1: 267–286.
    [71] Ferraresi C, Huang YY, Hamblin MR (2016) Photobiomodulation in human muscle tissue: an advantage in sports performance? J Biophotonics.
    [72] Ferraresi C, de Sousa MV, Huang YY, et al. (2015) Time response of increases in ATP and muscle resistance to fatigue after low-level laser (light) therapy (LLLT) in mice. Lasers Med Sci 30: 1259–1267. doi: 10.1007/s10103-015-1723-8
    [73] Silveira PC, Scheffer Dda L, Glaser V, et al. (2016) Low-level laser therapy attenuates the acute inflammatory response induced by muscle traumatic injury. Free Radic Res 50: 503–513. doi: 10.3109/10715762.2016.1147649
    [74] Pires de Sousa MV, Ferraresi C, Kawakubo M, et al. (2016) Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate. Neurophotonics 3: 015003. doi: 10.1117/1.NPh.3.1.015003
    [75] de Sousa MV, Ferraresi C, de Magalhaes AC, et al. (2014) Building, testing and validating a set of home-made von Frey filaments: A precise, accurate and cost effective alternative for nociception assessment. J Neurosci Methods 232: 1–5. doi: 10.1016/j.jneumeth.2014.04.017
    [76] Kobiela Ketz A, Byrnes KR, Grunberg NE, et al. (2016) Characterization of Macrophage/Microglial activation and effect of photobiomodulation in the spared nerve injury model of neuropathic pain. Pain Med: pnw144.
    [77] Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87: 149–158. doi: 10.1016/S0304-3959(00)00276-1
    [78] de Lima FM, Vitoretti L, Coelho F, et al. (2013) Suppressive effect of low-level laser therapy on tracheal hyperresponsiveness and lung inflammation in rat subjected to intestinal ischemia and reperfusion. Lasers Med Sci 28: 551–564. doi: 10.1007/s10103-012-1088-1
    [79] Silva VR, Marcondes P, Silva M, et al. (2014) Low-level laser therapy inhibits bronchoconstriction, Th2 inflammation and airway remodeling in allergic asthma. Respir Physiol Neurobiol 194: 37–48. doi: 10.1016/j.resp.2014.01.008
    [80] Rigonato-Oliveira N, Brito A, Vitoretti L, et al. (2017) Effect of low-level laser therapy on chronic lung inflammation in experimental model of asthma: A comparative study of doses. Lasers Surg Med 49: 36.
    [81] Huang YY, Gupta A, Vecchio D, et al. (2012) Transcranial low level laser (light) therapy for traumatic brain injury. J Biophotonics 5: 827–837. doi: 10.1002/jbio.201200077
    [82] Thunshelle C, Hamblin MR (2016) Transcranial low-level laser (light) therapy for brain injury. Photomed Laser Surg 34: 587–598. doi: 10.1089/pho.2015.4051
    [83] Hamblin MR (2016) Shining light on the head: Photobiomodulation for brain disorders. BBA Clin 6: 113–124. doi: 10.1016/j.bbacli.2016.09.002
    [84] Khuman J, Zhang J, Park J, et al. (2012) Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice. J Neurotrauma 29: 408–417. doi: 10.1089/neu.2010.1745
    [85] Veronez S, Assis L, Del Campo P, et al. (2017) Effects of different fluences of low-level laser therapy in an experimental model of spinal cord injury in rats. Lasers Med Sci 32: 343–349. doi: 10.1007/s10103-016-2120-7
    [86] Muili KA, Gopalakrishnan S, Eells JT, et al. (2013) Photobiomodulation induced by 670 nm light ameliorates MOG35-55 induced EAE in female C57BL/6 mice: a role for remediation of nitrosative stress. PLoS One 8: e67358. doi: 10.1371/journal.pone.0067358
    [87] Yoshimura TM, Sabino CP, Ribeiro MS (2016) Photobiomodulation reduces abdominal adipose tissue inflammatory infiltrate of diet-induced obese and hyperglycemic mice. J Biophotonics 9: 1255–1262. doi: 10.1002/jbio.201600088
    [88] Bjordal JM, Lopes-Martins RA, Iversen VV (2006) A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations. Br J Sports Med 40: 76–80. doi: 10.1136/bjsm.2005.020842
    [89] Hofling DB, Chavantes MC, Juliano AG, et al. (2010) Low-level laser therapy in chronic autoimmune thyroiditis: a pilot study. Lasers Surg Med 42: 589–596. doi: 10.1002/lsm.20941
    [90] Hofling DB, Chavantes MC, Juliano AG, et al. (2013) Low-level laser in the treatment of patients with hypothyroidism induced by chronic autoimmune thyroiditis: a randomized, placebo-controlled clinical trial. Lasers Med Sci 28: 743–753. doi: 10.1007/s10103-012-1129-9
    [91] Hofling DB, Chavantes MC, Juliano AG, et al. (2012) Assessment of the effects of low-level laser therapy on the thyroid vascularization of patients with autoimmune hypothyroidism by color Doppler ultrasound. ISRN Endocrinol 2012: 126720.
    [92] Hofling DB, Chavantes MC, Acencio MM, et al. (2014) Effects of low-level laser therapy on the serum TGF-beta1 concentrations in individuals with autoimmune thyroiditis. Photomed Laser Surg 32: 444–449. doi: 10.1089/pho.2014.3716
    [93] Hofling D, Chavantes MC, Buchpiguel CA, et al. (2017) Long-term follow-up of patients with hypothyroidism induced by autoimmune thyroiditis submitted to low-level laser therapy. Lasers Surg Med 49: 36.
    [94] Ferraresi C, Beltrame T, Fabrizzi F, et al. (2015) Muscular pre-conditioning using light-emitting diode therapy (LEDT) for high-intensity exercise: a randomized double-blind placebo-controlled trial with a single elite runner. Physiother Theory Pract: 1–8.
    [95] Ferraresi C, Dos Santos RV, Marques G, et al. (2015) Light-emitting diode therapy (LEDT) before matches prevents increase in creatine kinase with a light dose response in volleyball players. Lasers Med Sci 30: 1281–1287. doi: 10.1007/s10103-015-1728-3
    [96] Pinto HD, Vanin AA, Miranda EF, et al. (2016) Photobiomodulation therapy improves performance and accelerates recovery of high-level rugby players in field test: A randomized, crossover, double-blind, placebo-controlled clinical study. J Strength Cond Res 30: 3329–3338. doi: 10.1519/JSC.0000000000001439
    [97] Ferraresi C, Bertucci D, Schiavinato J, et al. (2016) Effects of light-emitting diode therapy on muscle hypertrophy, gene expression, performance, damage, and delayed-onset muscle soreness: case-control study with a pair of identical twins. Am J Phys Med Rehabil 95: 746–757. doi: 10.1097/PHM.0000000000000490
    [98] Johnston A, Xing X, Wolterink L, et al. (2016) IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol.
    [99] Ablon G (2010) Combination 830-nm and 633-nm light-emitting diode phototherapy shows promise in the treatment of recalcitrant psoriasis: preliminary findings. Photomed Laser Surg 28: 141–146. doi: 10.1089/pho.2009.2484
    [100] Choi M, Na SY, Cho S, et al. (2011) Low level light could work on skin inflammatory disease: a case report on refractory acrodermatitis continua. J Korean Med Sci 26: 454–456. doi: 10.3346/jkms.2011.26.3.454
    [101] Hamblin MR (2013) Can osteoarthritis be treated with light? Arthritis Res Ther 15: 120. doi: 10.1186/ar4354
    [102] Ip D (2015) Does addition of low-level laser therapy (LLLT) in conservative care of knee arthritis successfully postpone the need for joint replacement? Lasers Med Sci 30: 2335–2339. doi: 10.1007/s10103-015-1814-6
    [103] Brosseau L, Robinson V, Wells G, et al. (2005) Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis. Cochrane Database Syst Rev 19: CD002049.
    [104] Brosseau L, Welch V, Wells G, et al. (2004) Low level laser therapy (Classes I, II and III) for treating osteoarthritis. Cochrane Database Syst Rev: CD002046.
    [105] Barabas K, Bakos J, Zeitler Z, et al. (2014) Effects of laser treatment on the expression of cytosolic proteins in the synovium of patients with osteoarthritis. Lasers Surg Med 46: 644–649. doi: 10.1002/lsm.22268
    [106] Gregoriou S, Papafragkaki D, Kontochristopoulos G, et al. (2010) Cytokines and other mediators in alopecia areata. Mediators Inflamm 2010: 928030.
    [107] Avci P, Gupta GK, Clark J, et al. (2014) Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med 46: 144-151. doi: 10.1002/lsm.22170
    [108] Gupta AK, Foley KA (2017) A critical assessment of the evidence for low-level laser therapy in the treatment of hair loss. Dermatol Surg 43: 188–197. doi: 10.1097/DSS.0000000000000904
    [109] Yamazaki M, Miura Y, Tsuboi R, et al. (2003) Linear polarized infrared irradiation using Super Lizer is an effective treatment for multiple-type alopecia areata. Int J Dermatol 42: 738–740. doi: 10.1046/j.1365-4362.2003.01968.x
  • This article has been cited by:

    1. Shuang Chen, Yuanjin Ren, Small amplitude periodic solution of Hopf Bifurcation Theorem for fractional differential equations of balance point in group competitive martial arts, 2022, 7, 2444-8656, 207, 10.2478/amns.2021.2.00152
    2. Yuanyuan Ma, Nan Dong, Na Liu, Leilei Xie, Hopf bifurcation of the model with terms of two time-delays and delay-dependent parameter based on the theory of crossing curves, 2022, 32, 1054-1500, 103114, 10.1063/5.0095794
    3. Songkran Pleumpreedaporn, Chanidaporn Pleumpreedaporn, Jutarat Kongson, Chatthai Thaiprayoon, Jehad Alzabut, Weerawat Sudsutad, Dynamical Analysis of Nutrient-Phytoplankton-Zooplankton Model with Viral Disease in Phytoplankton Species under Atangana-Baleanu-Caputo Derivative, 2022, 10, 2227-7390, 1578, 10.3390/math10091578
    4. Muhammad Farman, Aamir Shehzad, Kottakkaran Sooppy Nisar, Evren Hincal, Ali Akgul, Ahmed Muhammad Hassan, Generalized Ulam-Hyers-Rassias stability and novel sustainable techniques for dynamical analysis of global warming impact on ecosystem, 2023, 13, 2045-2322, 10.1038/s41598-023-49806-7
    5. Kaushik Dehingia, Salah Boulaaras, Suman Gogoi, On the dynamics of a nutrient–plankton system with Caputo and Caputo–Fabrizio fractional operators, 2024, 76, 18777503, 102232, 10.1016/j.jocs.2024.102232
    6. R.N. Premakumari, Chandrali Baishya, Mohammad Esmael Samei, Manisha Krishna Naik, A novel optimal control strategy for nutrient–phytoplankton–zooplankton model with viral infection in plankton, 2024, 137, 10075704, 108157, 10.1016/j.cnsns.2024.108157
    7. Yumei Lin, Yuan Ma, Yunxian Dai, Stability and Hopf Bifurcation Control for Fractional-Order Two-Gene Regulatory Network With Multiple Delays, 2023, 11, 2169-3536, 58389, 10.1109/ACCESS.2023.3283401
  • Reader Comments
  • © 2017 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(45859) PDF downloads(4279) Cited by(656)

Figures and Tables

Figures(7)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog